Liquid Biopsy and Non-Invasive Diagnostics

Liquid Biopsy and Non-Invasive Diagnostics are cutting-edge techniques that enable the detection of cancer and monitoring of treatment responses without the need for traditional tissue biopsies. Liquid biopsy analyzes blood, urine, or other bodily fluids to detect cancer-related biomarkers such as circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), or other molecular markers. This method provides a less invasive, quicker alternative to tissue biopsies for early cancer detection, monitoring disease progression, and identifying genetic mutations that can guide treatment decisions. Non-invasive diagnostics also include advanced imaging techniques and biomarker tests that help identify cancer earlier, allowing for timely interventions with minimal discomfort or risk to the patient.

    Related Conference of Liquid Biopsy and Non-Invasive Diagnostics

    April 28-29, 2025

    35th Experts Meet On Cancer Research & Therapy

    Paris, France
    May 26-27, 2025

    15th World Congress on Breast Cancer

    Rome, Italy
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    July 14-15, 2025

    5th World Congress on Breast Cancer

    Berlin, Germany
    July 28-29, 2025

    45th Euro Congress on Cancer Science & Therapy

    Paris, France
    August 18-19, 2025

    6th Cancer Diagnostics & Treatment Conference

    Rome, Italy
    October 13-14, 2025

    8th International Conference on Anti-Cancer Drugs & Therapies

    Aix-en-Provence, France
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain
    November 24-25, 2025

    43rd World Cancer Conference

    Barcelona, Spain

    Liquid Biopsy and Non-Invasive Diagnostics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in